Esperion's Upcoming Participation at the Jefferies London Healthcare Conference
Esperion Therapeutics, recognized for its commitment to developing specialized treatments for cardiovascular and cardiometabolic conditions, is set to participate in the anticipated Jefferies London Healthcare Conference. This event is crucial for the company as it engages with investors and industry peers.
Event Details and Access
On November 19, 2024, at 11:30 a.m. ET, Esperion will present via a live webcast at the conference. Participants can tune in through the company's investor and media sections on its official website. This is an excellent opportunity for attendees to gain insights into the future directions of Esperion and its impact on healthcare.
Secure Webcast Access
Listeners can catch the live stream of the event, with a replay available shortly after the presentation. The archived version will remain accessible for approximately 90 days, allowing for flexible viewing options to suit various schedules.
About Esperion and Its Mission
Esperion is on a mission to create breakthrough therapies aimed at addressing the growing epidemic of high cholesterol. The company is dedicated to developing medications that effectively manage LDL-cholesterol levels, which is crucial in preventing cardiovascular diseases. By focusing on innovative solutions, Esperion is committed to helping doctors reach their patients’ health goals.
Innovative Solutions for High Cholesterol
As healthcare providers aim to reduce LDL-cholesterol levels effectively, Esperion plays a vital role in providing the necessary support. The team at Esperion understands that achieving cholesterol management is not just a task; it’s a necessity for patient well-being.
Commitment to Cardiovascular Health
Esperion acknowledges the realities faced by millions of individuals with high cholesterol. This awareness drives the company to innovate continuously, ensuring that their solutions meet the urgent health needs of patients. The focus remains on supporting individuals at risk for serious cardiovascular issues through its product offerings.
Connecting with Esperion
Esperion encourages interested investors and media representatives to reach out for further inquiries. The company emphasizes transparent communication, making it easy to stay updated on their developments and contributions to healthcare.
Contact Information
For investor-related questions, Alina Venezia is available at (734) 887-3903 or via email at investorrelations@esperion.com. For media inquiries, Tiffany Aldrich can be contacted at (616) 443-8438 or through email at corporateteam@esperion.com.
Frequently Asked Questions
What is the Jefferies London Healthcare Conference?
The Jefferies London Healthcare Conference is an event where companies showcase their advancements in the healthcare sector to investors and stakeholders.
When will Esperion present?
Esperion will present at 11:30 a.m. ET on November 19, 2024.
How can I access the presentation?
The live webcast can be accessed on Esperion's official website under the investor and media section.
Will the presentation be available afterward?
Yes, a replay of the presentation will be available about two hours after the live event and archived for approximately 90 days.
How can I contact Esperion for more information?
You can reach out to Alina Venezia for investor inquiries or Tiffany Aldrich for media inquiries using the provided contact information.
